155 related articles for article (PubMed ID: 7972255)
21. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.
Kuroki DW; Bignami GS; Wattenberg EV
Cancer Res; 1996 Feb; 56(3):637-44. PubMed ID: 8564984
[TBL] [Abstract][Full Text] [Related]
22. [Progress in the study of protein kinase C].
Zhang TF; Qin L
Sheng Li Ke Xue Jin Zhan; 1993 Apr; 24(2):123-6. PubMed ID: 8211061
[No Abstract] [Full Text] [Related]
23. [The role of protein kinase C in tumor growth].
Khodosova IA; Zakharova NV
Eksp Onkol; 1989; 11(3):3-9. PubMed ID: 2546729
[TBL] [Abstract][Full Text] [Related]
24. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin.
Galron D; Ansotegui IJ; Isakov N
Cell Immunol; 1997 Jun; 178(2):141-51. PubMed ID: 9225005
[TBL] [Abstract][Full Text] [Related]
25. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells.
Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M
Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
Basu A; Weixel K; Saijo N
Cell Growth Differ; 1996 Nov; 7(11):1507-12. PubMed ID: 8930400
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
[TBL] [Abstract][Full Text] [Related]
28. Results and speculations related to recent studies on mechanisms of tumor promotion.
Weinstein IB; Horowitz AD; Mufson RA; Fisher PB; Ivanovic V; Greenebaum E
Carcinog Compr Surv; 1982; 7():599-616. PubMed ID: 7039835
[No Abstract] [Full Text] [Related]
29. [Role of cell-cell interaction in tumor promotion].
Yamasaki H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):773-81. PubMed ID: 3963844
[TBL] [Abstract][Full Text] [Related]
30. Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters.
Kazanietz MG
Mol Carcinog; 2000 May; 28(1):5-11. PubMed ID: 10820483
[TBL] [Abstract][Full Text] [Related]
31. Initial cellular targets and eventual genomic changes in multistage carcinogenesis.
Weinstein IB; Gattoni-Celli S; Kirschmeier P; Lambert M; Hsiao W; Backer J; Jeffrey A
IARC Sci Publ; 1984; (56):277-97. PubMed ID: 6549538
[No Abstract] [Full Text] [Related]
32. The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation.
Clemens MJ; Trayner I; Menaya J
J Cell Sci; 1992 Dec; 103 ( Pt 4)():881-7. PubMed ID: 1487501
[No Abstract] [Full Text] [Related]
33. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
Cacace AM; Ueffing M; Philipp A; Han EK; Kolch W; Weinstein IB
Oncogene; 1996 Dec; 13(12):2517-26. PubMed ID: 9000126
[TBL] [Abstract][Full Text] [Related]
34. Control of fructose 2,6-bisphosphate metabolism by different mitogenic signals in Swiss 3T3 fibroblasts.
Dalmau M; Bartrons R; Gil J
Exp Cell Res; 1994 May; 212(1):93-6. PubMed ID: 8174646
[TBL] [Abstract][Full Text] [Related]
35. Transforming potentials of epidermal growth factor and nerve growth factor receptors inversely correlate with their phospholipase C gamma affinity and signal activation.
Obermeier A; Tinhofer I; Grunicke HH; Ullrich A
EMBO J; 1996 Jan; 15(1):73-82. PubMed ID: 8598208
[TBL] [Abstract][Full Text] [Related]
36. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
Laxminarayana D; Kammer GM
J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective versus tumorigenic protein kinase C activators.
Nelson TJ; Alkon DL
Trends Biochem Sci; 2009 Mar; 34(3):136-45. PubMed ID: 19233655
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase C and other diacylglycerol effectors in cancer.
Griner EM; Kazanietz MG
Nat Rev Cancer; 2007 Apr; 7(4):281-94. PubMed ID: 17384583
[TBL] [Abstract][Full Text] [Related]
39. Tumor promoters in human carcinogenesis.
Boutwell RK
Important Adv Oncol; 1985; ():16-27. PubMed ID: 3916738
[No Abstract] [Full Text] [Related]
40. Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy.
Grant S; Jarvis WD
Clin Cancer Res; 1996 Dec; 2(12):1915-20. PubMed ID: 9816149
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
